230 related articles for article (PubMed ID: 23791517)
21. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
[TBL] [Abstract][Full Text] [Related]
22. Meningococcal group A, C, Y and W-135 conjugate vaccine.
Harrison LH; Mohan N; Kirkpatrick P
Nat Rev Drug Discov; 2010 Jun; 9(6):429-30. PubMed ID: 20514064
[TBL] [Abstract][Full Text] [Related]
23. Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.
Jin Z; Bohach GA; Shiloach J; Norris SE; Freedberg DI; Deobald C; Coxon B; Robbins JB; Schneerson R
Infect Immun; 2005 Dec; 73(12):7887-93. PubMed ID: 16299279
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
25. Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
BMC Med Res Methodol; 2019 Jan; 19(1):1. PubMed ID: 30611213
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
Garrido R; Puyada A; Fernández A; González M; Ramírez U; Cardoso F; Valdés Y; González D; Fernández V; Vérez V; Vélez H
J Pharm Biomed Anal; 2012 Nov; 70():295-300. PubMed ID: 22877873
[TBL] [Abstract][Full Text] [Related]
27. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
Prinz DM; Smithson SL; Westerink MA
J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
[TBL] [Abstract][Full Text] [Related]
28. Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.
Menéndez T; Carmenate T; Cruz-Leal Y; Coizeau E; Caballero E; Bello D; Guirola M; Alvarez A; Guillén G
Curr Microbiol; 2010 Feb; 60(2):79-84. PubMed ID: 19771476
[TBL] [Abstract][Full Text] [Related]
29. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
Pace D
Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
[TBL] [Abstract][Full Text] [Related]
30. Simple alternative to sialic acid determination in meningococcal polysaccharides W or Y.
Morduš M; Štimac A; Brgles M; Kurtović T; Halassy B
J Pharm Biomed Anal; 2016 Feb; 120():283-9. PubMed ID: 26760246
[TBL] [Abstract][Full Text] [Related]
31. The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.
Gudlavalleti SK; Datta AK; Tzeng YL; Noble C; Carlson RW; Stephens DS
J Biol Chem; 2004 Oct; 279(41):42765-73. PubMed ID: 15294916
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A.
Torres-Sanchez MI; Zaccaria C; Buzzi B; Miglio G; Lombardi G; Polito L; Russo G; Lay L
Chemistry; 2007; 13(23):6623-35. PubMed ID: 17508372
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.
Findlow H; Borrow R
Adv Ther; 2013 May; 30(5):431-58. PubMed ID: 23712402
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.
Djibo S; Njanpop Lafourcade BM; Boisier P; Moussa A; Kobo G; Sidikou F; Hien A; Bieboure G; Aguilera JF; Parent du Chatelet I; Gessner BD; Chanteau S
Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):573-8. PubMed ID: 16406096
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
[TBL] [Abstract][Full Text] [Related]
36. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
37. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
38. In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy.
Gudlavalleti SK; Szymanski CM; Jarrell HC; Stephens DS
Carbohydr Res; 2006 Mar; 341(4):557-62. PubMed ID: 16406275
[TBL] [Abstract][Full Text] [Related]
39. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.
Enotarpi J; Tontini M; Balocchi C; van der Es D; Auberger L; Balducci E; Carboni F; Proietti D; Casini D; Filippov DV; Overkleeft HS; van der Marel GA; Colombo C; Romano MR; Berti F; Costantino P; Codeé JDC; Lay L; Adamo R
Nat Commun; 2020 Sep; 11(1):4434. PubMed ID: 32895393
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
Cook MC; Bliu A; Kunkel JP
Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
